Supported Reagents

To accelerate the cancer target discovery, CTD2 aims to disseminate knowledge, data, tools and resources with the scientific community. This page provides a list of materials (including plasmids, cell lines, cell models, etc.) which are generated by CTD2-supported research and are available for use by researchers. Each reagent listed is accompanied by a short description; more detailed information can be obtained from the generating laboratory (contact information provided). Some reagents are available through a distributor, while others are available directly from the generating laboratory. Many of these reagents require material transfer agreements (MTAs) for use. The requestor should work directly with the generating institution to complete the MTA. OCG will not be responsible for obtaining the MTA, but will provide information for contacting the generating laboratory. 

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRi) plasmids

CTD2 researchers at the University of California in San Francisco developed a modified Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) CRISPR/dCas9 system. Catalytically inactive dCas9 enables modular and programmable RNA-guided genome regulation in eukaryotes. The CRISPR/dCas9 system has several advantages:  i) enables robust gene repression (CRISPRi) or... Read More

Protein-Protein Interactions (PPI) reagents:

The CTD2 Center at Emory University has a library of genes used to study protein-protein interactions in mammalian cells. These genes are cloned in different mammalian expression vectors. A list of available cancer-associated genes can be accessed below.

... Read More